SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524636

INE102E01018

-9.9177201

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

200.97

EPS(TTM)

Face Value()

Div & Yield %

Back

Tarmat consolidated net profit rises 256.10% in the September 2025 quarter

Nov 15,2025

Net profit of Tarmat rose 256.10% to Rs 1.46 crore in the quarter ended September 2025 as against Rs 0.41 crore during the previous quarter ended September 2024. Sales rose 45.60% to Rs 22.67 crore in the quarter ended September 2025 as against Rs 15.57 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	22.67	15.57	46
OPM %	4.98	3.53	-
PBDT	1.67	0.56	198
PBT	1.39	0.38	266
NP	1.46	0.41	256

76,913.50 -582.86 ( -0.75%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)